The nation of Zimbabwe has turned down a significant American healthcare agreement valued at $367m (272 million pounds) over five years because of the United States' insistence on sensitive data.
This move became public after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "lopsided".
A government spokesperson later clarified that the US was requesting biological samples for scientific study and commercial purposes but was unwilling to share the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate process of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had provided over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for further negotiations to reach a deal acceptable to all parties so the country's vital HIV treatment initiative can be sustained.
Broader Implications
This rejection follows a comparable situation in Kenya, where a court halted a related health funding agreement after legal challenges were filed about the safety of Kenyans' health data.
After resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
The agency had overseen aid for the US government, but Trump argued its spending was "inefficient" and his administration was seeking government-to-government deals to boost transparency and responsibility.
According to reports, Sixteen nations in Africa have so far signed these new agreements, representing more than $18.3bn of fresh investment.
Specifics of the Declined Deal
The money for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment via American-funded programmes," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no equivalent promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Effectively, our nation would supply the basic resources for medical research without any certainty that the resulting innovations would be accessible to our people should a future disease outbreak arise."
National Interest and Global Health
He also noted that the US's withdrawal from the global health body and its push of bilateral health agreements were undermining systems previously established via the international health agency.
Mangwana cited its Pandemic Benefit-Sharing framework created to deal with potential pandemics.
"This system is designed to ensure that when a nation provides its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We encourage continued dialogue with our US partners on how subsequent co-operation might be arranged in a way that respects the independence and interests of both nations."
Health Experts Response
A leading public health body stated it recognised the government's concerns, but urged that talks should continue considering a large portion of the nation's HIV programmes depended on international support.
"If technical issues exist, including those involving data governance or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," the group said.
The situation emphasises the complex challenges between accepting much-needed foreign assistance and safeguarding local interests in an ever more interconnected world.